Features Screener Stocks Charts
Sign In Sign Up

AstraZenca Pharma India Ltd. Income Statement

NSE:ASTRAZEN | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year ASTRAZEN income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 13.30B 17.57B
Cost of Revenue -5.95B -9.63B
Gross Profit 7.36B 7.94B
Sales, General & Admin -5.17B -4.99B
Operating Income 2.04B 2.55B
Profit Before Tax 2.20B 1.56B
Net Income 1.62B 1.16B
Diluted Shares 25.00M 25.00M
Diluted EPS 64.60 46.30

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025